Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin

J. Posthuma de Boer, P.W. van Egmond, M.N. Helder, R. Xavier de Menezes, A.M. Cleton-Jansen, J.A.M. Belien, H.M.W. Verheul, B.J. van Royen, G.J.L. Kaspers, V.W. van Beusechem

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1169-1181
JournalOncotarget
Volume3
Issue number10
DOIs
Publication statusPublished - 2012

Cite this